此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Blended Collaborative Care for Heart Failure and Co-Morbid Depression

2020年8月3日 更新者:Bruce Rollman、University of Pittsburgh
Depression is highly prevalent among patients with heart failure (HF) and associated with lower levels of health-related quality of life and physical functioning, and higher risk of rehospitalization and mortality, and higher health costs. This Project will compare the effectiveness of a "blended" telephone-delivered collaborative care intervention for treating both HF and depression to: (1) collaborative care for HF-alone ("enhanced usual care"; eUC); and (2) doctors' "usual care" for depression (UC). If proven effective and cost-effective, the potentially more powerful, scalable, efficient "blended" care approach for treating HF and co-morbid depression could have profound implications for improving chronic illness care and stimulate development of "blended" interventions for treating other clusters of related medical conditions.

研究概览

详细说明

Heart failure (HF) is an important public health problem that affects approximately 6.6 million Americans. Despite improvements in cardiac care, it remains the leading cause for hospitalization among Medicare patients and the only major cardiovascular disease whose mortality rate has remained essentially unchanged over the past decade. This failure to improve HF outcomes may be due, in part, to unrecognized and/or inadequately treated depression that is highly prevalent in HF patients. Yet while new HF treatment guidelines advocate routine screening for depression, this recommendation is unlikely to be widely adopted without trial evidence that depression care improves outcomes and efficient methods to provide it.

"Collaborative care" strategies are being increasingly utilized to improve care for HF and other chronic medical conditions, and we recently demonstrated its clinical and cost-effectiveness at treating depression following coronary artery bypass graft surgery. Yet it may be impractical for health care delivery systems to support separate treatment programs for HF and depression. Thus we are encouraged by emerging evidence indicating "blended" collaborative care strategies that target both psychiatric and physical conditions produce greater improvements in mood symptoms and control of cardiovascular risk factors than programs focused solely on depression to propose testing a novel adaptation that could be provided in routine care.

The Specific Aims of this Project are to: (1) evaluate the effectiveness of a telephone-delivered "blended" collaborative care intervention for treating HF and depression that could be adopted into routine clinical practice if proven effective; and (2) advance our understanding of the moderators and mediators of depression treatment on clinical outcomes. We will screen hospitalized patients with systolic HF for depression, and then randomize 625 who screen positive and have at least a moderately elevated level of depressive symptoms at two-weeks following hospital discharge to either: (1) collaborative care for treating both HF and depression ("blended"); (2) collaborative care for treating HF alone (enhanced usual care (eUC)); or (3) their doctors' "usual care" (UC). Additionally, we will enroll 125 non-depressed HF patients to better evaluate the benefits derived from treating depression (total N=750). Our co-primary hypotheses will test whether "blended" collaborative care can produce at 12-months follow-up a: (A) 0.50 effect size (ES) or greater improvement in health-related quality of life (HRQoL) vs. UC; and (B) 0.30 ES or greater improvement in HRQoL vs. eUC. Secondary hypotheses will evaluate the effects of our "blended" intervention on mood, functional status, adherence with guideline-consistent care, incidence of cardiovascular events, health care utilization, and costs.

Improving chronic illness care for medically complex patients is one of the major challenges facing medicine today. We propose to test the effectiveness of an innovative, efficient, scalable, and sustainable intervention that could transform the way HF and other cardiovascular disorders are treated in routine practice.

研究类型

介入性

注册 (实际的)

756

阶段

  • 阶段2
  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Pennsylvania
      • Pittsburgh、Pennsylvania、美国、15213
        • University of Pittsburgh

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

21年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Systolic heart failure (documented ejection fraction ≤ 40%).
  2. HF symptoms meeting criteria for New York Heart Association (NYHA) classes II, III or IV.
  3. Inpatient two-item Patient Health Questionnaire (PHQ-2) screen-positive for depression; or PHQ-2 screen negative for depression and PHQ-9 <5 if non-depressed control.
  4. PHQ-9 ≥ 10 when reassessed two-weeks following hospital discharge, or PHQ-9 <5 if non-depressed control.
  5. No cognitive impairment (as documented in the record, use of donepezil or similar medications for treating cognitive impairment, or the Montreal Cognitive Assessment).
  6. Able to be evaluated and treated for depression as an outpatient.
  7. English speaking, not illiterate, or possessing any other communication barrier.
  8. Have a household telephone.

Exclusion Criteria:

  1. Receiving active treatment for a mood or anxiety disorder from a mental health specialist.
  2. Unstable medical condition as indicated by history, physical, and/or laboratory findings.
  3. Presence of non-cardiovascular conditions likely to be fatal within 12 months (e.g., cancer).
  4. Organic mood syndromes, including those secondary to medical illness or drugs.
  5. Active suicidal ideation.
  6. Current or history of psychotic illness.
  7. Current or history of bipolar illness according to patient self-report, past medical history, and diagnostic criteria.
  8. Current alcohol or other substance abuse as evidenced by chart review and the AUDIT-C questionnaire.
  9. Age ≤ 21 years.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Collaborative Care for Heart Failure + Depression

Collaborative care program for heart failure and depression involving a nurse care manager providing counseling and treatment advice via telephone

Interventions:

Behavioral:

Counseling for heart failure self-care Counseling for depression

Drug:

Pharmacotherapy for heart failure Pharmacotherapy for depression

Nurse care managers will provide patients with education for their heart failure to facilitate self-management for their condition. In addition, the nurse will telephone the patient to review with their medical history, medications, diet, activity and sleep patterns, and plans for follow-up medical appointments, and offer basic care coordination relative to heart failure care including assistance attaining authorization for home health services in concert with the patient's primary care physician (PCP), and follow-up appointments.

After case review with a study internist, the care manager may send treatment recommendations to the patient's physician(s) regarding guideline-indicated care. Afterwards, the care manager will telephone the patient approximately every other week to monitor and promote adherence with recommended care, and suggest adjustments in treatment as applicable following discussion with the clinical team and notification of the patient's PCP and cardiologist.

The care manager will telephone patients randomized to "blended" care patient to review their psychiatric history including use of antidepressant pharmacotherapy, herbal supplements, and alcohol possibly used to self-medicate depressive symptoms; provide basic psychoeducation about depression and its impact on cardiac disease; recommend various self-management strategies (e.g., sufficient rest and exercise); and describe treatment options. They will include: (1) use of a workbook or computer program to enhance patients' understanding and ability to self-care; (2) initiation or adjustment of antidepressant pharmacotherapy prescribed under their primary care physicians' direction; or (3) referral to a local mental health specialist. The nurse will then telephone the patient to monitor symptoms and pharmacotherapy use, practice skills imparted through workbook assignments, promote adherence with recommended care, and suggest adjustments in treatment as applicable.
有源比较器:Collaborative Care for Heart Failure Only

Collaborative care program for heart failure and depression involving a nurse care manager providing counseling and treatment advice via telephone

Interventions:

Behavioral:

Counseling for heart failure self-care Usual care for depression

Drug:

Pharmacotherapy for heart failure

Usual Care for depression

Nurse care managers will provide patients with education for their heart failure to facilitate self-management for their condition. In addition, the nurse will telephone the patient to review with their medical history, medications, diet, activity and sleep patterns, and plans for follow-up medical appointments, and offer basic care coordination relative to heart failure care including assistance attaining authorization for home health services in concert with the patient's primary care physician (PCP), and follow-up appointments.

After case review with a study internist, the care manager may send treatment recommendations to the patient's physician(s) regarding guideline-indicated care. Afterwards, the care manager will telephone the patient approximately every other week to monitor and promote adherence with recommended care, and suggest adjustments in treatment as applicable following discussion with the clinical team and notification of the patient's PCP and cardiologist.

无干预:Usual Care for Heart Failure and Depression
Control group will receive their doctors' usual care for heart failure and depression
无干预:Non-Depressed Comparison Cohort
Control group will receive their doctors' usual care for heart failure

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Medical Outcomes Study (MOS) 12-Item Short Form Health Survey Mental Component Summary (SF-12 MCS)
大体时间:12-Months Follow-Up
Mental Health-Related Quality of Life
12-Months Follow-Up

次要结果测量

结果测量
措施说明
大体时间
Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
大体时间:12-Month Follow-Up
Disease-Specific Health-Related Quality of Life
12-Month Follow-Up
Hamilton Rating Scale for Depression (17-Item)
大体时间:12-Months Follow-Up
Mood symptoms
12-Months Follow-Up
Incidence of Rehospitalization
大体时间:12-Month Follow-Up
12-Month Follow-Up
Mortality
大体时间:12-Month Follow-Up
All-Cause and Cardiovascular Mortality
12-Month Follow-Up
Health Care Costs
大体时间:12-Month Follow-Up
Claims data
12-Month Follow-Up
Employment
大体时间:12-Months Follow-Up
12-Months Follow-Up

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Bruce L. Rollman, MD, MPH、University of Pittsburgh

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2014年2月1日

初级完成 (实际的)

2018年10月1日

研究完成 (实际的)

2020年7月1日

研究注册日期

首次提交

2014年1月21日

首先提交符合 QC 标准的

2014年1月21日

首次发布 (估计)

2014年1月23日

研究记录更新

最后更新发布 (实际的)

2020年8月5日

上次提交的符合 QC 标准的更新

2020年8月3日

最后验证

2020年8月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅